Form 8-K - Current report:
SEC Accession No. 0001193125-20-112164
Filing Date
2020-04-20
Accepted
2020-04-20 16:15:42
Documents
13
Period of Report
2020-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d893504d8k.htm   iXBRL 8-K 20117
5 GRAPHIC g893504g0420051359037.jpg GRAPHIC 2307
  Complete submission text file 0001193125-20-112164.txt   145594

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20200420.xsd EX-101.SCH 3075
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20200420_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20200420_pre.xml EX-101.PRE 10956
8 EXTRACTED XBRL INSTANCE DOCUMENT d893504d8k_htm.xml XML 3210
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 20802705
SIC: 2836 Biological Products, (No Diagnostic Substances)